Coromandel International Ltd logo

Coromandel International Ltd

COROMANDEL NSE

Key Fundamentals

MidcapFertilizersChemicals
Market Cap
₹61,452 Cr
Volatility
Moderate
P/E Ratio
33.21
EBITDA
₹3,564 Cr
Return on Equity
14.45%
Debt to Equity
0.12
Book Value
₹425.67
EPS
₹49.55
52W High
₹2,500
52W Low
₹1,706.5

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Coromandel International Ltd insights

39 extracted metrics + investor summaries across FY13–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Growth Rate

Revenue Growth
30.21%
Net Income Growth
-7.62%
Cash Flow Change
-36.78%
ROE
-21.08%
ROCE
-15.85%
EBITDA Margin (Avg.)
-8.35%

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 2d ago
AI opinion · based on fundamentals
Risk medium

Coromandel International is a ₹61,856 Cr market cap agri-solutions leader that posted 30.7% revenue growth in FY26 to ₹31,480 Cr, though net profit grew only 3.48% to ₹2,009 Cr due to margin pressures. The stock trades at a PE of 34.7x with a near-zero net debt position, reflecting its strong balance sheet against a backdrop of slowing profit growth and sector cyclicality.

Bull Case 8
  • FY26 revenue grew 30.7% YoY to ₹31,480 Cr, demonstrating strong topline momentum after 9.2% growth in FY25
  • Net debt-to-equity ratio stands at 0.0x, providing a virtually debt-free balance sheet with significant capacity for future capex or acquisitions
  • 10-year compounded profit CAGR of 19% reflects a sustained long-term earnings trajectory across cycles
  • Crop protection segment contribution rose from 10% in FY25 to 12% in FY26, indicating successful diversification beyond fertilisers into higher-margin businesses
  • EBITDA grew 14.3% YoY to ₹3,452 Cr in FY25 (pre-tax basis), showing operating leverage even during input cost volatility
  • 10-year stock price CAGR of 23% and 5-year CAGR of 20% demonstrate consistent long-term wealth creation
  • Expansion into bio-products, specialty nutrients, nano fertilisers, and agri-drone spraying opens new addressable markets beyond traditional fertilisers
  • 5-year compounded sales CAGR of 17% outpaces the broader Indian chemicals sector average, reflecting market share gains
Bear Case 8
  • TTM compounded profit growth is -6%, indicating near-term earnings compression despite strong revenue growth
  • PE ratio of 34.7x is elevated for a fertiliser-heavy business where margins are subject to government subsidy timing and raw material volatility
  • Net profit grew only 3.48% to ₹2,009 Cr in FY26 despite 30.7% revenue growth, signalling significant margin erosion from input cost inflation and subsidy lags
  • 3-year compounded profit CAGR of -1% shows earnings have essentially stagnated over the medium term despite revenue recovery
  • Dividend yield of just 0.53% offers minimal income return relative to the stock's valuation premium
  • Stock has delivered -11% return over the past 1 year, underperforming broader indices and indicating market scepticism on near-term earnings
  • ROE has declined from a 5-year average of 20% to 16% in the last year, suggesting diminishing capital efficiency
  • Heavy dependence on fertiliser segment (approximately 88% of FY25 revenue) exposes the company to subsidy policy changes and raw material price swings in phosphoric acid and ammonia

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 20h ago
Headwinds 1
  • Net profit dips on cost pressure Aug 1

    Q1FY27 net profit fell to ₹382 crore despite revenue growth, squeezed by high input costs and subsidy gaps.

Positives 2
  • Revenue up 15% YoY in Q1 Aug 1

    Coromandel reported ₹8,215 crore revenue in Q1FY27, a 15% year-on-year increase indicating strong topline momentum.

  • Dividend approved at 64th AGM Jul 23

    Shareholders approved FY26 financials and final dividend at the AGM held on July 23, 2026, along with re-election of director Arunachalam Vellayan.

Neutral 2
  • Q1FY27 earnings call held Jul 25

    Coromandel hosted its analyst/investor conference call on July 24, 2026 at 2:30 PM IST and uploaded the audio recording and investor presentation per SEBI norms.

  • AGM governance outcomes disclosed Jul 23

    The 64th AGM on July 23, 2026 completed all statutory approvals including financials, dividend, and director re-election.

TL;DR: Coromandel's topline is growing robustly at 15% YoY to ₹8,215 crore, but profitability is under pressure from elevated input costs and subsidy timing gaps. Shareholder returns remain intact with an approved dividend. The key risk is whether margin compression persists if subsidy reimbursements remain delayed and raw material costs stay elevated in coming quarters.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
5,693
6,988
5,464
3,913
4,729
7,433
6,935
4,988
7,042
9,654
8,779
6,004
8,165
Expenses
4,988
5,933
5,115
3,650
4,238
6,471
6,222
4,579
6,260
8,508
7,980
5,516
7,409
Operating Profit
706
1,055
349
263
490
962
713
409
782
1,147
800
488
756
OPM %
12%
15%
6%
7%
10%
13%
10%
8%
11%
12%
9%
8%
9%
Other Income
44
45
59
84
54
65
114
473
84
116
83
-6
50
Interest
41
46
38
62
57
66
73
66
68
102
84
89
89
Depreciation
48
54
64
63
65
69
71
85
121
102
147
165
203
PBT
661
1,000
306
222
422
892
683
731
677
1,059
653
228
514
Tax %
25%
25%
25%
26%
27%
26%
26%
21%
26%
25%
25%
50%
26%
Net Profit
494
755
228
164
309
659
508
578
502
793
488
115
382
EPS in Rs
16.8
25.71
7.85
5.45
10.56
22.55
17.37
19.67
17.13
27.31
17.15
4.74
12.91
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
11,306
11,481
10,031
11,083
13,225
13,137
14,182
19,111
29,628
22,058
24,085
31,480
32,602
Expenses
10,450
10,712
9,048
9,822
11,775
11,400
12,193
16,954
26,726
19,678
21,508
28,248
29,412
Operating Profit
856
769
983
1,261
1,450
1,737
1,989
2,156
2,902
2,380
2,577
3,232
3,190
OPM %
8%
7%
10%
11%
11%
13%
14%
11%
10%
11%
11%
10%
10%
Other Income
50
87
54
55
8
35
76
141
171
223
703
262
243
Interest
210
221
224
178
251
235
106
75
190
187
262
343
364
Depreciation
105
106
101
99
114
158
173
173
182
229
290
534
616
PBT
592
529
712
1,038
1,093
1,379
1,786
2,050
2,701
2,188
2,728
2,617
2,454
Tax %
32%
32%
33%
33%
34%
23%
26%
25%
25%
25%
25%
27%
Net Profit
402
357
477
691
720
1,065
1,329
1,528
2,013
1,641
2,055
1,898
1,778
EPS in Rs
13.8
12.27
16.35
23.64
24.63
36.36
45.3
52.08
68.46
55.78
70.14
66.31
62.11
Div. Payout %
33%
33%
31%
27%
26%
33%
26%
23%
18%
11%
21%
3%
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
29
29
29
29
29
29
29
29
29
29
29
30
Reserves
2,173
2,605
2,862
2,867
3,329
4,288
5,121
6,329
7,878
9,390
11,058
12,528
Borrowings
2,288
2,677
2,228
2,728
2,954
2,019
385
395
393
492
780
1,506
Other Liabilities
3,872
3,871
3,526
4,224
4,261
3,812
3,360
4,532
5,934
5,933
7,049
10,397
Total Liabilities
8,362
9,182
8,645
9,848
10,574
10,149
8,895
11,285
14,235
15,845
18,917
24,461
Fixed Assets
1,380
1,320
1,328
1,327
1,309
2,032
2,015
2,092
2,200
3,112
4,139
6,737
CWIP
46
42
22
48
191
65
90
141
399
235
396
348
Investments
352
477
388
221
201
211
214
243
287
854
1,031
2,044
Other Assets
6,583
7,343
6,907
8,252
8,873
7,840
6,576
8,809
11,348
11,644
13,351
15,331
Total Assets
8,362
9,182
8,645
9,848
10,574
10,149
8,895
11,285
14,235
15,845
18,917
24,461
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
86
18
915
263
526
1,862
4,150
2,078
591
1,428
2,464
1,558
Investing
-216
-61
-79
38
-597
-220
-1,245
-1,622
640
-1,333
-2,638
-559
Financing
-64
8
-864
-1
-244
-1,723
-2,263
-443
-543
-363
-698
-831
Net Cash Flow
-194
-34
-28
300
-314
-82
642
14
688
-269
-872
168
Free Cash Flow
-6
-89
834
134
255
1,606
3,958
1,801
22
910
2,030
22
CFO/OP
27
25
120
49
62
128
232
119
45
86
123
71
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
47
52
59
52
50
48
14
5
7
23
19
24
Inventory Days
96
98
88
109
127
109
98
94
69
102
98
111
Days Payable
131
135
150
162
147
135
110
100
83
119
123
136
Cash Conversion Cycle
12
15
-3
-2
30
22
2
-1
-7
6
-7
-1
Working Capital Days
11
24
40
27
42
65
64
41
37
46
28
35
ROCE %
19%
15%
18%
23%
23%
26%
32%
35%
38%
26%
23%
22%

Shareholding Pattern

As of Jun 2026
Promoters 56.35%
DIIs 19.92%
FIIs 11.50%
Public 7.61%
Others 4.62%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
57.56%
57.56%
57.54%
57.53%
57.53%
57.48%
57.44%
57.41%
57.41%
57.40%
57.33%
57.33%
57.32%
57.31%
57.17%
56.97%
56.96%
56.90%
56.88%
56.86%
56.35%
56.35%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
7.19%
0.00%
7.34%
7.52%
7.79%
8.33%
10.61%
14.29%
14.51%
13.80%
13.02%
11.50%
DIIs
16.59%
18.02%
15.38%
16.09%
16.39%
15.52%
18.69%
18.03%
18.90%
20.63%
21.14%
19.63%
20.67%
20.82%
21.26%
21.02%
18.98%
15.86%
15.79%
16.70%
18.20%
19.92%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
9.20%
8.64%
8.93%
8.78%
9.37%
9.50%
9.42%
9.60%
9.66%
9.72%
9.59%
9.81%
9.69%
9.36%
8.77%
8.81%
8.63%
8.27%
8.18%
7.93%
7.72%
7.61%
Others
16.66%
15.78%
18.15%
17.61%
16.72%
17.50%
14.44%
14.96%
14.03%
12.25%
4.75%
13.24%
4.97%
5.00%
5.01%
4.87%
4.82%
4.68%
4.64%
4.71%
4.70%
4.62%
No. of Shareholders
1,01,161
96,227
1,14,352
1,12,677
1,15,440
1,39,667
1,42,752
1,33,758
1,32,103
1,32,344
1,23,639
1,26,628
1,36,412
1,36,497
1,41,349
1,40,959
1,43,560
1,43,623
1,45,222
1,34,655
1,37,335
1,30,118

Documents

Frequently Asked Questions about Coromandel International Ltd

What does Coromandel International Ltd do?
Business Segments [1] a) Nutrient and Other Allied Business (88% in FY26 vs 90% in FY25):: i) Fertilizers: [2] [3] [4] [5] It manufactures NPK, DAP, SSP, MOP, and urea. It is India's 2nd-largest manufacturer and marketer of phosphatic fertilizers, the largest manufacturer and marketer of SSP, th...
Where is Coromandel International Ltd (COROMANDEL) listed?
Coromandel International Ltd is listed on the Indian stock exchanges. It is listed on NSE: COROMANDEL and BSE: 506395. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Coromandel International Ltd belong to?
Coromandel International Ltd operates in the Chemicals sector within the Fertilizers industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Coromandel International Ltd?
Coromandel International Ltd has a market capitalisation of approximately ₹61451.55 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Coromandel International Ltd?
The Price-to-Earnings (PE) ratio of Coromandel International Ltd is 33.21. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Coromandel International Ltd?
Over the past 52 weeks, Coromandel International Ltd has traded between a low of ₹1,706.5 and a high of ₹2,500. This range helps investors understand the stock's price volatility and recent trading levels.
Does Coromandel International Ltd pay dividends?
Yes, Coromandel International Ltd has a dividend yield of 0.52%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Coromandel International Ltd?
Coromandel International Ltd has a Return on Equity (ROE) of 14.45%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Coromandel International Ltd on Tapetide?
On Tapetide, you can view Coromandel International Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Business Segments [1] a) Nutrient and Other Allied Business (88% in FY26 vs 90% in FY25):: i) Fertilizers: [2] [3] [4] [5] It manufactures NPK, DAP, SSP, MOP, and urea. It is India's 2nd-largest manufacturer and marketer of phosphatic fertilizers, the largest manufacturer and marketer of SSP, the largest private-sector NPK player, and a pioneering leader in the Nano DAP segment. It also holds a 35% share in the unique products segment and a 17.5% market share on a consumption basis. ii) Specialty Nutrients: [4] [3] The company is the pioneer & market leader in India's specialty nutrients segment, offering water-soluble fertilizers, secondary and micronutrients, and nano fertilizer products. iii) Organic Fertilizers: [6] [3] The company markets organic fertilizers, producing a range of products derived from natural sources such as city waste, sugarcane molasses and its by-products, oil cakes, and gypsum. b) Crop Protection (12% in FY26 vs 10% in FY25):: i) Crop Protection: [7] [8] [3] The company manufactures and markets a range of insecticides, fungicides, herbicides, plant growth regulators, technicals and formulations in India and international markets. It is the country's 4th-largest agrochemical player by value, with the capability to manufacture 20 technicals and intermediates. It is also the 2nd-largest manufacturer of Malathion globally and a major manufacturer of Phenthoate in Asia. ii) Bio Products: [4] [9] [10] Bio Products business focuses on plant-based extracts for agricultural applications, offering a comprehensive portfolio of biopesticides based on Azadirachtin, plant-derived biostimulants, anti-transpirants and non-ionic spreaders. It holds a global leadership position in the Azadirachtin market, with a presence across more than 40 countries in the Americas, Europe and Asia. Sale Volumes (in Lakh MT):[11] NPK+DAP: 42.77 in FY26 vs 39.88 in FY25 SSP: 8.41 in FY26 vs 7.73 in FY25 MOP: 0.67 in FY26 vs 0.69 in FY25 Urea: 22.65 in FY26 vs 13.59 in FY25 Geographical Split[12] Domestic: 94% in FY26 vs 95% in FY25 Exports: 6% in FY26 vs 5% in FY25 Retail Presence[13] [4] [14] The company operates India's largest agri-retail network with over 1,200 agri-retail outlets across Andhra Pradesh, Telangana, Karnataka, Tamil Nadu and Maharashtra. It is supported by over 3,000 marketing professionals and serves more than 5 Mn farmers across its operating markets. It has a network of 12,000 channel partners. New Product Launches[15] In FY26, Coromandel expanded its portfolio with new launches across Specialty Nutrients, Crop Protection and Bio Products. It's key additions included Fertinex 28:28:0, GypMax, Novonese, Organovita and Summit in Specialty Nutrients; Daliso, Ghibli, Chhaava and Invicto in Crop Protection; and CoroBT, GroBT, Coroscens, CoroShakti and other biological solutions to strengthen its bio-products portfolio. Manufacturing Capabilities[4] [16] The company operates 21 manufacturing facilities across India, with a total capacity of: Fertilizers: 3.5 Mn MT SSP: 1 Mn MT Specialty Nutrients: 87,500 MT Nano Fertilizers: 10,000 KL Crop Protection Chemicals: 0.87 Lakh MT Bio Products: 22.5 MT Expansion & Backward Integration[17] [18] The company commissioned a 2,000 TPD sulphuric acid plant and a 650 TPD phosphoric acid plant at Kakinada in Q4 FY26, for Rs. 1,100 Cr. It also advanced construction of the 7.5 lakh TPA NPK granulation Train H at Kakinada, expected to increase the site's total fertilizer capacity to 30 lakh TPAby Q4 FY27. Additionally, its Senegal rock phosphate project, where the company holds a 53.8% stake, commissioned a fixed processing plant and ramped up production to secure raw material supplies for the Kakinada phosphoric acid facility. It also added a 9 KTPA technical plant at Dahej for off-patent fungicides, along with capacity additions for key technical molecules at Ankleshwar and a herbicide block expansion at Sarigam. Acquisitions[19] [17] In Aug 2025, the company acquired a 53.13% controlling stake in NACL Industries for Rs. 820 Cr. MoU[20] In Nov 2025, the company signed a non-binding MoU with the Andhra Pradesh Economic Development Board to explore investments of up to Rs. 2,000 Cr in Andhra Pradesh. Focus[21] The company expects a 20-25% revenue growth in the crop protection business.

CEO Mr. Arun Alagappan
Employees 5,540
Listed 1995-05-31
Face Value ₹ 1
Issued Size 29,49,95,409

Explore More